ArticleFrontiers in pharmacology2022

The proteolysis targeting chimera GMB-475 combined with dasatinib for the treatment of chronic myeloid leukemia with BCR::ABL1 mutants.

Wu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.